Association of TAP2 gene polymorphisms in Chinese patients with rheumatoid arthritis

The aim of this study was to investigate the association between the polymorphism of transporters associated with antigen processing (TAP1/TAP2) genes and rheumatoid arthritis in Chinese patients. A total of 100 RA patients and 99 healthy control subjects were enrolled. Analyses with polymerase chain reaction (PCR) based restrictions were used to identify the polymorphisms of the TAP1 and TAP2 genes, which were mapped on chromosome 6. There was a significant difference in the distribution of the TAP2 gene codon 565 polymorphism frequency between the RA patients and healthy control subjects (p<0.001). The odds ratio for the risk of the ‘A’ allele in RA patients was 1.60 (95% CI: 0.82–2.92). No statistical associations in the distribution of the TAP1 gene polymorphism frequency were found between RA patients and controls. There were some physical links found between TAP1/TAP2 gene polymorphism loci. However, there was no linkage observed from TAP1/TAP2 gene polymorphisms and HLA-DRB1*04 between RA patients and healthy controls. We concluded that the TAP2 gene codon 565 ‘A’ allele was associated with RA in Chinese patients in Taiwan. Individuals possessing the ‘A’ allele had a higher incidence of RA. A lack of association of TAP1 gene polymorphisms between RA patients and healthy individuals was noted. The results of this study provide genetic evidence that TAP2 gene codon 565 polymorphism may play a role in RA.

[1]  Association of vitamin D receptor gene BsmI polymorphisms in Chinese patients with systemic lupus erythematosus , 2002, Lupus.

[2]  J. Neefjes,et al.  Peptide size selection by the major histocompatibility complex-encoded peptide transporter , 1994, The Journal of experimental medicine.

[3]  F. Arnett.  Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.

[4]  N. Huskisson,et al.  Effect of polymorphism of an MHC-linked transporter on the peptides assembled in a class I molecule , 1992, Nature.

[5]  H. Nakagawa,et al.  Lack of primary association between transporter associated with antigen processing genes and atopic dermatitis. , 1995, The Journal of allergy and clinical immunology.

[6]  S Beck,et al.  Polymorphism in a second ABC transporter gene located within the class II region of the human major histocompatibility complex. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[7]  O. Olerup,et al.  HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. , 1992, Tissue antigens.

[8]  T Spies,et al.  Allelic variants of the human putative peptide transporter involved in antigen processing. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[9]  A. Zwinderman,et al.  Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Results of a followup study. , 1991, Arthritis and rheumatism.

[10]  P. Gregersen,et al.  The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. , 1987, Arthritis and rheumatism.

[11]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[12]  K. Pile,et al.  Analysis of the MHC-encoded transporters TAP1 and TAP2 in rheumatoid arthritis: linkage with DR4 accounts for the association with a minor TAP2 allele. , 1993, Tissue antigens.

[13]  C. Morimoto,et al.  Dual‐label immunocytochemistry of the active multiple sclerosis lesion: Major histocompatibility complex and activation antigens , 1988, Annals of neurology.

[14]  F. Tsai,et al.  No association of vitamin D receptor gene start codon fok 1 polymorphisms in Chinese patients with systemic lupus erythematosus. , 2002, The Journal of rheumatology.

[15]  U. Wagner,et al.  HLA markers and prediction of clinical course and outcome in rheumatoid arthritis. , 1997, Arthritis and rheumatism.

[16]  G. Kingsley,et al.  The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. , 1992, Arthritis and rheumatism.

[17]  D. Faustman.  Mechanisms of autoimmunity in type I diabetes , 2004, Journal of Clinical Immunology.

[18]  S. Beck,et al.  A proteasome-related gene between the two ABC transporter loci in the class II region of the human MHC , 1991, Nature.

[19]  K. Isselbacher,et al.  Polymorphisms involving the transmembrane domains of human TAP2 , 2004, Immunogenetics.

[20]  M. Creemers.  Ankylosing spondylitis: what do we really know about the onset and progression of this disease? , 2002, The Journal of rheumatology.

[21]  L. Field,et al.  Report of the committee on the genetic constitution of chromosome 6. , 1990, Cytogenetics and cell genetics.

[22]  S. Krane,et al.  Rheumatoid arthritis: clinical features and pathogenetic mechanisms. , 1986, The Medical clinics of North America.

[23]  F. Tsai,et al.  Lack of association of interleukin-1ß gene polymorphisms in Chinese patients with systemic lupus erythematosus , 2002, Rheumatology International.

[24]  P. Geusens,et al.  Peptide transporter genes (TAP) polymorphisms and genetic susceptibility to rheumatoid arthritis. , 1995, British journal of rheumatology.

[25]  S. Beck,et al.  Second proteasome-related gene in the human MHC class II region , 1991, Nature.

[26]  J. Monaco,et al.  A molecular model of MHC class-I-restricted antigen processing. , 1992, Immunology today.

[27]  L. Moreland,et al.  New approaches to the therapy of autoimmune diseases: rheumatoid arthritis as a paradigm. , 1993, The American journal of the medical sciences.

[28]  C. Mathew.  Science, medicine, and the future: Postgenomic technologies: hunting the genes for common disorders. , 2001, BMJ.